In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach. TB remains the leading cause of death by infectious disease globally, with South...
In a study from Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), researchers have generated a map of the cellular circuitry of Mycobacterium tuberculosis, the causative agent of...
A handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. Two...